03/16/2026
Meet the dynamic DeBoer Lab team at the Byers Eye Institute!
Led by Dr. Charles DeBoer, this team is focused on creating smarter, longer-lasting treatments for eye diseases that affect millions of people worldwide. Their goal is to simply improve vision and quality of life by developing new technologies that deliver medication more effectively inside the eye.
One of the lab's main areas of work is building tiny implantable devices—so small they’re measured in microns—that can release medication slowly and steadily over weeks or even months. These micro-implants are designed to treat chronic retinal conditions like macular degeneration and uveitis, reducing the need for frequent injections and making treatment easier for patients.
The DeBoer Lab team also explores innovative cell-based therapies, using specially engineered cells to safely produce and deliver therapeutic proteins directly where they’re needed. In addition, the team designs new surgical tools to help eye surgeons perform delicate procedures with greater precision and safety.
This interdisciplinary team brings together experts in engineering, biology, pharmacology, and medicine, working side by side to turn cutting-edge research into real-world solutions for eye care.
Learn more about the DeBoer Lab and the work they're doing here: https://buff.ly/Klo4KjN